These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9193583)

  • 1. Infusion of class II DIM donor bone marrow enhances islet allograft survival in low-dose CyA treated dogs.
    Kenyon NS; Selvaggi G; Fernandez L; Xu XM; Knapp J; Montelongo J; McMannis J; Russell TR; Alejandro R; Ricordi C
    Transplant Proc; 1997 Jun; 29(4):2189. PubMed ID: 9193583
    [No Abstract]   [Full Text] [Related]  

  • 2. Synergy of class I and class II MHC deficiency (C1D and C2D) islets and early short-term suppression in achieving long-term islet graft survival and tolerance induction.
    Pittman K; Berzina P; Contreras J; Bilbao G; Thomas F; Thomas J
    Transplant Proc; 1999; 31(1-2):635-6. PubMed ID: 10083271
    [No Abstract]   [Full Text] [Related]  

  • 3. A composite graft of islet plus donor lymph node cells induced donor specific tolerance in a "low responder" rat combination with class I MHC disparity.
    Maeda A; Ito T; Yumiba T; Ohkawa A; Uchikoshi F; Tori M; Sawai T; Nozawa M; Matsuda H
    Transplant Proc; 1999; 31(1-2):749-50. PubMed ID: 10083320
    [No Abstract]   [Full Text] [Related]  

  • 4. T-cell-directed immunosuppression allows prolonged survival of xenogeneic pig islets in monkeys.
    Jonker M; Rijkelijkhuizen JK; Haanstra KG; Kuhn EM; Ringers J; Bouwman E
    Transplant Proc; 2001; 33(1-2):726. PubMed ID: 11267041
    [No Abstract]   [Full Text] [Related]  

  • 5. Canine islet allograft survival after donor specific vertebral body derived bone marrow cell transplantation without irradiation conditioning of the recipient.
    Brendel MD; Kong SS; Schachner RD; Qian T; Selvaggi G; Alejandro R; Mintz DH; Ricordi C
    Transplant Proc; 1995 Dec; 27(6):3174. PubMed ID: 8539895
    [No Abstract]   [Full Text] [Related]  

  • 6. Requirement for DR sharing in stable kidney allograft tolerance induced by donor bone marrow in rhesus monkeys.
    Thomas J; Kasten-Jolly J; Verbanac K; Smith JP; Carver M; Gross U; Rebellato L; Thomas F; Haisch C
    Transplant Proc; 1995 Feb; 27(1):686-8. PubMed ID: 7879146
    [No Abstract]   [Full Text] [Related]  

  • 7. The influence of donor specific vertebral body derived bone marrow cell infusion on canine islet allograft survival without irradiation conditioning of the recipient.
    Brendel MD; Kong SS; Schachner RD; Qian T; Selvaggi G; Alejandro R; Mintz DH; Ricordi C; Federlin K; Bretzel RG
    Exp Clin Endocrinol Diabetes; 1995; 103 Suppl 2():129-32. PubMed ID: 8839269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of antilymphocyte serum, fractionated donor bone marrow, and cyclosporine on renal allograft survival in mongrel dogs.
    Hartner WC; Markees TG; De Fazio SR; Khouri W; Maki T; Monaco AP; Gozzo JJ
    Transplantation; 1991 Nov; 52(5):784-9. PubMed ID: 1835194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mixed allogeneic chimerism achieved by lethal and nonlethal conditioning approaches induces donor-specific tolerance to simultaneous islet allografts.
    Li H; Colson YL; Ildstad ST
    Transplantation; 1995 Sep; 60(6):523-9. PubMed ID: 7570945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The facilitating effect of one-DR antigen sharing in renal allograft tolerance induced by donor bone marrow in rhesus monkeys.
    Thomas JM; Verbanac KM; Smith JP; Kasten-Jolly J; Gross U; Rebellato LM; Haisch CE; Carver FM; Thomas FT
    Transplantation; 1995 Jan; 59(2):245-55. PubMed ID: 7839448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term islet allograft function in the absence of chronic immunosuppression: a case report of a nonhuman primate previously made tolerant to a renal allograft from the same donor.
    Kawai T; Sogawa H; Koulmanda M; Smith RN; O'Neil JJ; Wee SL; Boskovic S; Sykes M; Colvin RB; Sachs DH; Auchincloss H; Cosimi AB; C Ko DS
    Transplantation; 2001 Jul; 72(2):351-4. PubMed ID: 11477369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The contribution of MHC antigen modulation to islet allograft rejection.
    Markmann JF; Schachner MS; Bassiri H; Barker CF; Naji A
    Horm Metab Res Suppl; 1990; 25():104-8. PubMed ID: 2088947
    [No Abstract]   [Full Text] [Related]  

  • 13. Experience with islet immunoalteration in dogs: in vitro and in vivo studies.
    Kenyon NS; Alejandro R; Mintz DH
    Horm Metab Res Suppl; 1990; 25():119-22. PubMed ID: 2088950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced allograft acceptance by multiple infusions of donor bone marrow in humans.
    Ricordi C; Karatzas T; Selvaggi G; Neri J; Fernandez H; Ruiz MP; Linetsky E; Kong SS; Webb M; Bottino R
    Transplant Proc; 1995 Dec; 27(6):3381. PubMed ID: 8540006
    [No Abstract]   [Full Text] [Related]  

  • 15. Intrathymic xenogeneic pancreatic islet transplantation--induction of donor-specific unresponsiveness by MHC class II peptides.
    Zeng Y; Torres M; Wang Y; Montag A; Thistlethwaite JR
    Transplant Proc; 1995 Feb; 27(1):176-7. PubMed ID: 7878961
    [No Abstract]   [Full Text] [Related]  

  • 16. Ia-positive donor-specific bone marrow cells prolong renal allografts in dogs treated with fractionated lymphoid irradiation.
    Watanabe K; Taniai S; Sato K; Sonoda K; Masaki Y; Takahara H; Matsubayashi T; Kashiwagi N
    Transplant Proc; 1987 Feb; 19(1 Pt 1):632-4. PubMed ID: 2978927
    [No Abstract]   [Full Text] [Related]  

  • 17. T-cell-specific immunosuppression results in more than 53 days survival of porcine islets of langerhans in the monkey.
    Rijkelijkhuizen JK; Haanstra KG; Wubben J; Töns A; Roos A; van Gijlswijk-Janssen DJ; Ringers J; Bouwman E; Jonker M
    Transplantation; 2003 Nov; 76(9):1359-68. PubMed ID: 14627916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of rapamycin on islet and skin xenograft survival.
    Bobbio SA; Porter JG; Monaco AP
    Transplant Proc; 1993 Aug; 25(4):2745-6. PubMed ID: 8356733
    [No Abstract]   [Full Text] [Related]  

  • 19. The degree of phylogenetic disparity of islet grafts dictates the reliance on indirect CD4 T-cell antigen recognition for rejection.
    Rayat GR; Johnson ZA; Beilke JN; Korbutt GS; Rajotte RV; Gill RG
    Diabetes; 2003 Jun; 52(6):1433-40. PubMed ID: 12765954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of anti-Ia antibodies, culture, and cyclosporin on prolongation of canine islet allograft survival.
    Alejandro R; Latif Z; Noel J; Shienvold FL; Mintz DH
    Diabetes; 1987 Mar; 36(3):269-73. PubMed ID: 3100370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.